Pharmacokinetic and pharmacodynamic profiles of subcutaneous administration of continuous erythropoietin receptor activator in lung cancer patients with anemia induced by chemotherapy

Author：            

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.2, Iss.6, 2011-01, pp. : 1033-1040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy

By Vincent Mark   Dranitsaris George   Verma Sunil   Lau Cathy   Gascon Pere   Belle Simon   Ludwig Heinz  

Supportive Care in Cancer, Vol. 15, Iss. 3, 2007-03 ,pp. : 265-272

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacodynamic model for chemotherapy-induced anemia in rats

By Woo Sukyung   Krzyzanski Wojciech   Jusko William  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite

Editorial comment on: “The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer receiving palliative chemotherapy”. by Vincent et al.

By Korte Wolfgang  

Supportive Care in Cancer, Vol. 15, Iss. 3, 2007-03 ,pp. : 239-241

Springer Publishing Company

Access to resources Recommend Favorite

Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer

By Zarogoulidis K.   Papagiannis A.   Ziogas E.   Fahantidou E.   Dermitzakis G.   Gioulekas D.   Vamvalis C.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2428-2431

Elsevier

Access to resources Recommend Favorite

A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer

By Sculier J.P.   Paesmans M.   Thiriaux J.   Lecomte J.   Bureau G.   Giner V.   Koumakis G.   Lafitte J.J.   Berchier M.C.   Alexopoulos C.G.   Zacharias C.   Mommen P.   Ninane V.   Klastersky J.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1314-1319

Elsevier

Access to resources Recommend Favorite